No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
DH Definitive Healthcare
- 6.990
- -0.260-3.59%
Trading Apr 25 09:39 ET
823.35MMarket Cap-3905P/E (TTM)
7.100High6.990Low9.23KVolume7.100Open7.250Pre Close65.11KTurnover0.02%Turnover RatioLossP/E (Static)117.79MShares12.45552wk High0.96P/B372.26MFloat Cap5.53052wk Low--Dividend TTM53.26MShs Float50.300Historical High--Div YieldTTM1.52%Amplitude5.530Historical Low7.058Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Definitive Healthcare Announces Timing of Its First Quarter 2024 Financial Results Conference Call and Webcast
FRAMINGHAM, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. ("Definitive Healthcare") (NASDAQ:DH), an industry leader in healthcare commercial intelligence, today announced that it will report
Definitive Healthcare Introduces Carevoyance Sales Enablement Solution for Medtech Industry
Medtech commercial teams can now solve frontline sales challenges with exceptional data and streamlined workflowsFRAMINGHAM, Mass., April 16, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq:
VML and Definitive Healthcare Announce Partnership to Transform Key Opinion Leader Management
FRAMINGHAM, Mass. and LONDON, March 22, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (NASDAQ:DH) and VML Health announced a first-of-its-kind partnership that gives clients the ability to manage their entire key
Needham Reaffirms Their Hold Rating on Definitive Healthcare Corp (DH)
Definitive Healthcare Earns 2024 Middle Market Leader Award From Boston Business Journal
FRAMINGHAM, Mass., March 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it has been named one of the Boston Business
Definitive Healthcare Had the Biggest Increase in Short Selling Among Software Stocks - Baird
Comments
Definitive Healthcare's inflated P/S ratio might not be sustainable long term without short-term significant outperformance of the wider industry.
What Definitive Healthcare Corp.'s (NASDAQ:DH) 31% Share Price Gain Is Not Telling You
ColumnsTop upgrades and downgrades on 7/6: MRK, EOG, ABT, UNP and more
Upgrades
• $A.O. Smith(AOS.US$ : Longbow Research Upgrades to Buy from Neutral - PT $71
• $Callon Petroleum(CPE.US$ : RBC Upgrades to Outperform from Sector Perform - PT $75
• $Dun & Bradstreet(DNB.US$ : BofA Securities Upgrades to Neutral from Underperform - PT $17 (from $16)
•$Enanta Pharmaceuticals(ENTA.US$ : Evercore ISI Upgrades to Outperform from In Line - PT $62 (from $39)
• $Corning(GLW.US$ : CFRA Upgrades to Strong Buy ...
• $A.O. Smith(AOS.US$ : Longbow Research Upgrades to Buy from Neutral - PT $71
• $Callon Petroleum(CPE.US$ : RBC Upgrades to Outperform from Sector Perform - PT $75
• $Dun & Bradstreet(DNB.US$ : BofA Securities Upgrades to Neutral from Underperform - PT $17 (from $16)
•$Enanta Pharmaceuticals(ENTA.US$ : Evercore ISI Upgrades to Outperform from In Line - PT $62 (from $39)
• $Corning(GLW.US$ : CFRA Upgrades to Strong Buy ...
8
IPO Demand is getting stronger
2021 is a strong year for initial public offerings. This timing is right close to the easing of lockdowns. As we recalled back to 2019, it was a totally dissapointing market debuts and failures. Some highly anticipated tech cos such as $Uber Technologies(UBER.US$ made headlines for their lack of profitability. The public market spoke and Uber ended 219 with some of the most dissapointing public offerings.
Right now, the pipeline of prospects, IPO prospects is very strong driven by the pandemic. Personally, I think the resiliency of the economy is mainly driven by the hunger of the investors. More and more confidence coming to the markets $Definitive Healthcare(DH.US$$DICE THERAPEUTICS, INC.(DICE.US$$Brown & Brown(BRO.US$ are some of the companies that set the tone. People feel like it's the right time for investors to take that equity risk.
Right now, the pipeline of prospects, IPO prospects is very strong driven by the pandemic. Personally, I think the resiliency of the economy is mainly driven by the hunger of the investors. More and more confidence coming to the markets $Definitive Healthcare(DH.US$$DICE THERAPEUTICS, INC.(DICE.US$$Brown & Brown(BRO.US$ are some of the companies that set the tone. People feel like it's the right time for investors to take that equity risk.
1
Last week (13 Sep to 17 Sep 2021) IPO result
Stocks on IPO and during their first year will face extreme volatility 
. The stocks will requires many conditions, such as good management, good business plan and good luck, to ensure its survival. Investors, especially new ones, will need to pick them more carefully. 
Here is the result for last week IPO stocks. Did you got the right ones?
. The stocks will requires many conditions, such as good management, good business plan and good luck, to ensure its survival. Investors, especially new ones, will need to pick them more carefully. Here is the result for last week IPO stocks. Did you got the right ones?
7
Strong Demand for IPOs
IPOs see strong demand as investors are seeking new companies that offer innovative products and services in wide ranging and diverse areas. A number of well received IPOs have enjoyed terrific returns which could be attributed to market exuberance over these new listings. This comes as no surprise as the US market is the mainstay of most global portfolios of investors and also home to multiple fast growing companies across various industries. With the market reaching new all time highs, concerns are increasing about new listings overheating. The newly listed companies also tend to be more volatile during their first few earnings seasons as market expectations will rest on if they could deliver the promised targets. Investors need to be aware that early institutional investors look to exit their holdings within a year or so while retail investors are buying in, which results in increased volatility. Investment decisions should always be guided by a fundamental analysis of the company and its valuation to ensure that investors are not taking unnecessary risks to their portfolios by jumping on this IPO bandwagon blindly.
$Definitive Healthcare(DH.US$
$DICE THERAPEUTICS, INC.(DICE.US$
$Dutch Bros(BROS.US$
$On Holding(ONON.US$
$PROCEPT BioRobotics(PRCT.US$
$Sportradar Group AG(SRAD.US$
$Thoughtworks(TWKS.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
$Definitive Healthcare(DH.US$
$DICE THERAPEUTICS, INC.(DICE.US$
$Dutch Bros(BROS.US$
$On Holding(ONON.US$
$PROCEPT BioRobotics(PRCT.US$
$Sportradar Group AG(SRAD.US$
$Thoughtworks(TWKS.US$
$TYRA BIOSCIENCES, INC.(TYRA.US$
37
24
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg